Cardiac markers: From enzymes to proteins, diagnosis to prognosis, laboratory to bedside

Annals of Clinical and Laboratory Science

Volumn 29, Issue 1, 1999, Pages 18-23

  Wu, Alan H B ^a  

^a HARTFORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; CREATINE KINASE MB; ISOENZYME; LACTATE DEHYDROGENASE; MYOGLOBIN; TROPONIN I; TROPONIN T;

ACUTE HEART INFARCTION; ARTICLE; CARDIOVASCULAR DISEASE; DISEASE MARKER; ENZYME ACTIVITY; HEART DEATH; HEART MUSCLE REVASCULARIZATION; HUMAN; LABORATORY TEST; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; UNSTABLE ANGINA PECTORIS;

BIOLOGICAL MARKERS; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; MYOCARDIAL INFARCTION; MYOCARDIUM; POINT-OF-CARE SYSTEMS; PROGNOSIS; PROTEINS;

ANGINA;

EID: 0032995852     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. LaDue JS, Wróblewski F, Karmen A. Serum glutamic oxaloacetic transaminase activity in human acute transmural myocardial infarction. Science 1954;120: 497-500.
2. Karmen A, Wröblewski F, LaDue JS. Transaminase activity in human blood. J Clin Invest 1954;34:126-31.
3. Karmen A. A note on the spectrophotometric assay of glutamic-oxaloacetic transaminase in human blood serum. J Clin Invest 1954;34:131-3.
4. Wróblewski F, Ladue JS. Lactic dehydrogenase activity in blood. Proc Soc Exper Biol & Med 1955; 90:210-3.
5. Wacker WEC, Ulmer DD, Valle BL. Metal isoonzymes and myocardial infarction, malic and lactic dehydrogenase activities and zinc concentrations in serum. N Engl J Med 1956;255:449-56.
6. Ebashi S, Toyokura Y, Momoi H, Sugita H. High creatine phosphokinase activity of sera of progressive muscular dystrophy. J Biochem 1959;46:103-4.
7. Dreyfus JC, Schapira G, Resnais J, Scebat L. La creatine kinase serique dans le diagnostic de l'infaretus myocardique. Rev Franc Etud Clin et Biol 1960;5: 386-11.
8. Sorensen NS. Creatine phosphokinase in the diagnosis of myocardial infarction. Acta Medica Scand 1963; 174:725-34.
9. Oliver IT. A spectrophotometric method for the determination of creatine phosphokinase and myokinase. Biochem J 1955;61:116-22.
10. Rosalki SB. An improved procedure for serum creatine phosphokinase determination. J Lab Clin Med 1967;69:696-705.
11. World Health Organization. Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature. Nomenclature and criteria for diagnosis of ischemic heart disease. Circulation 1979; 59:607-9.
12. Wróblewski F, Ross C, Gregory K. Isoenzymes of myocardial infarction. N Engl J Med 1960;263:531-6.
13. Roe CR, Limbird LE, Wagner CS, Nerenberg ST. Combined isoenzyme analysis in the diagnosis of myocardial injury: Application of electrophoretic methods for the detection and quantitation of creatine kinase phosphokinase MB isoenzyrne. J Lab Clin Med 1972; 80:577-90.
14. Mercer DW. Separation of tissue and serum creatine kinase isoenzymes by ion-exchange column chromatography. Clin Chem 1974;20:36-40.
15. Mercer DW. Simultaneous separation of serum creatine kinase and lactate dehydrogenase isoenzymes by ion-exchange column chromatography. Clin Chem 1975;21:1102-6.
16. Jockers-Wretou E, Pfleiderer G. Quantitation of creatine kinase isoenzymes in human tissues and sera by an immunological method. Clin Chim Acta 1975;58: 223-32.
17. Wu AHB, Herson VC, Bowers GN Jr. Macro creatine kinase type 1 and 2: Clinical significance in neonates and children as compared with adults. Clin Chem 1983;29:201-4.
18. Usatequi-Gomez M, Wicks RW, Warshaw M. Immunochemical determination of the heart isoenzyme of lactate dehydrogenase (LDHI) in human serum. Clin Chem 1979;25:729-34.
19. Onigbinde TA, Wu AHB, Johnson M, Wu YS, Collinsworth WL, Simmons MJ. Clinical evaluation of an automated chemical inhibition assay for lactate dehydrogenase (LD)-1 isoenzyme. Clin Chem 1990;36: 1819-22.
20. Chan DW, Taylor E, Frye T, Blitzer RL. Immunoenzymetric assay for creatine kinase MB with subunit-specific monoclonal antibodies compared with an immunochemical method and electrophoresis. Clin Chem 1985;31:465-9.
21. Wu AHB, Gornet TG, Bretaudiere JP, Panfili PR. Comparison of enzyme immimoassay and immunoinhibition for creatine kinase MB in diagnosis of acute myocardial infarction. Clin Chem 1985;31:470-4.
22. Vaidya HC, Maynard Y, Dietzler DN, Ladenson JH. Direct measurement of creatine kinase-MB activity in serum after extraction with a monoclonal antibody specific to the MB isoenzyme. Clin Chem 1986;32: 657-63.
23. Wu AHB. Creatine kinase isoforms in ischemic heart disease. Clin Chem 1989;35:7-13.
24. Puleo PR, Meyer D, Wathen C, Tawa CB, Wheelers S, Hamburg RJ, Ali N, Obermueller SD, Triana JF, Zimmerman JL, Perryman MB, Roberts R. Use of a rapid assay of subforms of creatine kinase-MB to diagnose or rule out acute myocardial infarction. N Engl J Med 1994;331:561-6.
25. Puleo PR, Guadagno PA, Roberts R, Perryman MB. Sensitive, rapid assay of subforms of creatine kinase MB in plasma. Clin Chem 1989;35:1452-5.
26. Gilkeson G, Stone MJ, Waterman M, Ting R, Gomez-Sanchez CE, Hull A, Willerson, JT. Detection of myoglobin by radioimmunoassay in human sera: its usefulness and limitations as an emergency room screening test for acute myocardial infarction. Am Heart J 1978;95:70-77.
27. Wu AHB, Laios I, Green S, Gornet TG, Wong SS, Parmaley L, Tonnesen A, Plaisier B, Orlando R. Immunoassays for serum and urine myoglobin: myoglobin clearance assessed as a risk factor for acute renal failure. Clin Chem 1994;40:796-802.
28. Gibler WB, Runyon JP, Levy RC, Sayre MR, Kacich R, Hattemer CR, Hamilton C, Gerlach JW, Walsh RA. A rapid diagnostic and treatment center for patients with chest pain in the emergency department. Ann Emerg Med 1995;25:1-8.
29. Wu AHB. Use of cardiac markers as assessed by outcomes analysis. Clin Biochem 1997;30:339-50.
30. Gibler WB, Gibler CD, Weinshenker E, Abbottsmith C, Hedges JR, Barsan WG, Sperling M, Chen IW, Embry S, Kereiakes D. Myoglobin as an early indicator of acute myocardial infarction. Ann Emerg Med 1987;16:851-6.
31. Katus HA, Remppis A, Looser S, Hallermeier K, Scheffold T, Kubler W. Enzyme linked immuno assay of cardiac troponin T for the detection of acute myocardial infarction in patients. J Mol Cell Cardiol 1989; 21:1349-53.
32. Bodor GS, Porter S, Landt Y, Ladenson JH. Development of monoclonal antibodies for the assay of cardiac troponin I and preliminary results in suspected cases of myocardial infarction. Clin Chem 1992;38: 2203-14.
33. Wu AHB, Valdes R Jr, Apple FS, Gornet T, Stone MA, Mayfield-Stokes S, Ingersoll-Stroubos AM, Wiler B. Cardiac troponin-T immunoassay for diagnosis of acute myocardial infarction and detection of minor myocardial injury. Clin Chem 1994;40:900-7.
34. Cummins B, Auckland ML, Cummins P. Cardiac specific troponin I radioimmunoassay in the diagnosis of acute myocardial infarction. Am Heart J 1987;113: 1333-14.
35. Hamm CW, Ravkilde J, Gerhardt W, Jorgensen P, Peheim E, Ljungdah, L. The prognostic value of serum troponin T in unstable angina. N Engl J Med 1992;327:146-50.
36. Antman EM, Tanasijevic MJ, Thompson B, Schactman M, McCabe CH, Cannon CP, Fischer GA, Fung AY, Thompson C, Wybenga D, Braunwald E. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996;335:1342-9.
37. Herrick JB. Clinical features of sudden obstruction of the coronary arteries. JAMA 1912;59:2015-20.
38. TIMI Study Group. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med 1989;320:618-27.
39. Topol EJ, Califf RM, Kereiakes DJ, George BS. Thrombolysis and angioplasty in myocardial infarction (TAMI) trial. J Am Coll Cardiol 1987;10(5 Suppl B): 65-74B.
40. Zabel M, Hohnloser SH, Koster W, et al. Analysis of creatine kinase, CK-MB, myoglobin, and troponin T time-activity curves for early assessment of coronary artery reperfusion after intravenous thrombolysis. Circulation 1993;87:1542-50.
41. Christenson RH. Point-of-care testing for cardiac markers. In: Wu, AHB, editor. Cardiac Markers. Totowa: Humana Press, 1998:259-80.
42. Wu AHB, Apple FS, Gibler B, Jesse RL, Valdes R Jr., Warshaw M. Standards of laboratory practice: recommendations for use of cardiac markers in coronary artery diseases. Clin Chem 1998;44:subinitted.